These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
100 related articles for article (PubMed ID: 27229524)
1. Does an Acid-Milieu in Chronic Kidney Disease Contribute to Its Increased Cardiovascular Mortality? Wesson DE Am J Nephrol; 2016; 43(6):408-10. PubMed ID: 27229524 [No Abstract] [Full Text] [Related]
2. Update on inflammation in chronic kidney disease. Akchurin OM; Kaskel F Blood Purif; 2015; 39(1-3):84-92. PubMed ID: 25662331 [TBL] [Abstract][Full Text] [Related]
3. Epidemiology: The global burden of reduced GFR: ESRD, CVD and mortality. Sharma S; Sarnak MJ Nat Rev Nephrol; 2017 Aug; 13(8):447-448. PubMed ID: 28626221 [No Abstract] [Full Text] [Related]
4. A prospective, multicenter, randomized, controlled study: the correction of metabolic acidosis with use of bicarbonate in Chronic Renal Insufficiency (UBI) Study. Di Iorio B; Aucella F; Conte G; Cupisti A; Santoro D J Nephrol; 2012; 25(3):437-40. PubMed ID: 21928233 [TBL] [Abstract][Full Text] [Related]
5. Chronic kidney disease: a new opportunity for better cardiovascular risk stratification. Hallan SI J Intern Med; 2009 Oct; 266(4):414-7. PubMed ID: 19765183 [No Abstract] [Full Text] [Related]
6. Vitamin D status and mortality in chronic kidney disease. Pilz S; Tomaschitz A; Friedl C; Amrein K; Drechsler C; Ritz E; Boehm BO; Grammer TB; März W Nephrol Dial Transplant; 2011 Nov; 26(11):3603-9. PubMed ID: 21378153 [TBL] [Abstract][Full Text] [Related]
8. Cystatin C identifies cardiovascular risk better than creatinine-based estimates of glomerular filtration in middle-aged individuals without a history of cardiovascular disease. Svensson-Färbom P; Ohlson Andersson M; Almgren P; Hedblad B; Engström G; Persson M; Christensson A; Melander O J Intern Med; 2014 May; 275(5):506-21. PubMed ID: 24279862 [TBL] [Abstract][Full Text] [Related]
9. The association of chronic kidney disease-mineral bone disorder and cardiovascular risk. Eddington H; Kalra PA J Ren Care; 2010 May; 36 Suppl 1():61-7. PubMed ID: 20586901 [TBL] [Abstract][Full Text] [Related]
15. Cardiovascular risk in patients with chronic kidney disease: not high enough to enter the major league? Zoccali C Curr Hypertens Rep; 2008 Feb; 10(1):1-2. PubMed ID: 18367018 [No Abstract] [Full Text] [Related]
16. [Prevalence of anemia, calcium-phosphorus abnormalities and metabolic acidosis in different stages of chronic renal failure]. Zarzecki M; Chudek J; Kukla M; Kopeć P; Mamcarz E; Wnuk Z; Kokot F; Wiecek A Pol Arch Med Wewn; 2004 Oct; 112(4):1211-9. PubMed ID: 15773434 [TBL] [Abstract][Full Text] [Related]
17. The finding of reduced estimated glomerular filtration rate is associated with increased mortality in a large UK population. Quinn MP; Cardwell CR; Kee F; Maxwell AP; Savage G; McCarron P; Fogarty DG Nephrol Dial Transplant; 2011 Mar; 26(3):875-80. PubMed ID: 20713975 [TBL] [Abstract][Full Text] [Related]
18. Strengths and weaknesses of renal markers as risk factors and surrogate markers. Johnson KR Kidney Int; 2011 Jun; 79(12):1272-4. PubMed ID: 21625257 [TBL] [Abstract][Full Text] [Related]
19. Mild decrease in estimated glomerular filtration rate and proteinuria are associated with all-cause and cardiovascular mortality in the general population. Oh SW; Baek SH; Kim YC; Goo HS; Heo NJ; Na KY; Chae DW; Kim S; Chin HJ Nephrol Dial Transplant; 2012 Jun; 27(6):2284-90. PubMed ID: 22140122 [TBL] [Abstract][Full Text] [Related]
20. Antioxidants for chronic kidney disease. Jun M Nephrology (Carlton); 2013 Aug; 18(8):576-8. PubMed ID: 23865542 [No Abstract] [Full Text] [Related] [Next] [New Search]